EP1807067A4 - Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci - Google Patents

Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci

Info

Publication number
EP1807067A4
EP1807067A4 EP05817632A EP05817632A EP1807067A4 EP 1807067 A4 EP1807067 A4 EP 1807067A4 EP 05817632 A EP05817632 A EP 05817632A EP 05817632 A EP05817632 A EP 05817632A EP 1807067 A4 EP1807067 A4 EP 1807067A4
Authority
EP
European Patent Office
Prior art keywords
same
treating agent
skin disease
sphingosine kinase
kinase activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05817632A
Other languages
German (de)
English (en)
Other versions
EP1807067A1 (fr
Inventor
Byeong-Deog Park
Jong-Kyung Youm
Hyung-Sub Gwak
Mi-Jong Kwon
Yong-Moon Lee
Yoo-Hun Kim
Hwan-Mook Kim
Song-Kyu Park
Ki-Ho Lee
Chang-Woo Lee
Myong-Lyoll Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neopharm Co Ltd
Original Assignee
Neopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020050096591A external-priority patent/KR100607438B1/ko
Application filed by Neopharm Co Ltd filed Critical Neopharm Co Ltd
Publication of EP1807067A1 publication Critical patent/EP1807067A1/fr
Publication of EP1807067A4 publication Critical patent/EP1807067A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
EP05817632A 2004-11-03 2005-10-27 Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci Withdrawn EP1807067A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040088553 2004-11-03
KR1020050096591A KR100607438B1 (ko) 2004-11-03 2005-10-13 스핑고신키나제 활성화제를 포함하는 피부질환치료제
PCT/KR2005/003586 WO2006049404A1 (fr) 2004-11-03 2005-10-27 Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci

Publications (2)

Publication Number Publication Date
EP1807067A1 EP1807067A1 (fr) 2007-07-18
EP1807067A4 true EP1807067A4 (fr) 2010-08-18

Family

ID=36319380

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05817632A Withdrawn EP1807067A4 (fr) 2004-11-03 2005-10-27 Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci

Country Status (2)

Country Link
EP (1) EP1807067A4 (fr)
WO (1) WO2006049404A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008023998A1 (fr) * 2006-08-22 2008-02-28 Industrial Research Limited N-acyléthanolamines utilisées comme agents de cicatrisation des plaies
KR101750238B1 (ko) * 2016-04-27 2017-06-27 (주)네오팜 항노화용 조성물
KR101828240B1 (ko) * 2016-10-17 2018-02-13 (주)네오팜 항염용 조성물
KR101828241B1 (ko) * 2016-10-17 2018-02-13 (주)네오팜 항염용 조성물
CN113861060B (zh) * 2021-11-05 2023-12-08 江苏弘和药物研发有限公司 一种鞘氨醇激酶激动剂的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334210A1 (de) * 1983-09-22 1985-04-04 Henkel KGaA, 4000 Düsseldorf Ethoxylierungsprodukte von hydroxycarbonsaeureamiden und ihre verwendung als schaumarme tenside
KR19980034991A (ko) * 1996-11-11 1998-08-05 안용찬 비천연세라미드 관련화합물 및 이를 함유하는 피부외용제

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CASTIEL-HIGOUNENC I ET AL: "AUGMENTATION DU CONTENU EN CERAMIDES DES EPIDERMES HUMAINS RECONSTRUITS APRES TRAITEMENT AVEC UN SPHINGOLIPIDE EXOGENE A BASE SPHINGANINE//EXOGENOUS SPHINGANIN DERIVED SPHINGOLIPID INCREASES EPIDERMAL CERAMIDE CONTENT IN HUMAN RECONSTRUCTED SKIN", NOUVELLES DERMATOLOGIQUES, STRASBOURG, FR, vol. 18, no. 8, 1 January 1999 (1999-01-01), pages 541 - 546, XP008022965, ISSN: 0752-5370 *
See also references of WO2006049404A1 *

Also Published As

Publication number Publication date
WO2006049404A1 (fr) 2006-05-11
EP1807067A1 (fr) 2007-07-18

Similar Documents

Publication Publication Date Title
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
HK1216080A1 (zh) 用於治療或預防草酸鹽相關疾病的組合物和方法
EP1814909A4 (fr) Utilisation de aimp2dx2 pour diagnostiquer et traiter un cancer
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
HK1096092A1 (en) Benzamide derivatives and their use as glucokinase activating agents
EP1871245A4 (fr) Systemes de dilatation de tissu et procedes associes
EP1758605A4 (fr) Prouroguanyline servant d'agents therapeutiques ou diagnostiques
IL186616A (en) Spyro-oxa-indoles and their use as drugs
PL379553A1 (pl) Ligandy receptora waniloidowego oraz ich zastosowanie w leczeniu
HK1110508A1 (en) Compositions and methods of their use for improving the condition and appearance of skin
EP1874800A4 (fr) Agents diagnostiques et thérapeutiques
SI1921077T1 (sl) Sredstvo za zdravljenje in/ali preprečevanje motnje spanja
EP1891929A4 (fr) Produit cosmetique pour la peau et agent reduisant les rides
EP1781685A4 (fr) Agents therapeutiques et diagnostiques
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
HK1105361A1 (en) Skin conditioning agent
EP1736173A4 (fr) Agent therapeuthique de tissu endommage et procéde therapeutique
ZA200705881B (en) Formulations and treatments for well-being
EP1840948A4 (fr) Agent de traitement fin et procede de traitement fin l'utilisant
EP1807067A4 (fr) Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci
EP1944039A4 (fr) Médicament de traitement de tumeurs et son utilisation dans la fabrication de médicaments de traitement de tumeurs
GB2411834B (en) Composition for use in the treatment of dry skin conditions
EP1776956A4 (fr) Agent préventif et/ou thérapeutique pour la calcipénie
EP1951914A4 (fr) Méthodes et agents diagnostiques et thérapeutiques
ZA200707510B (en) Benzoxazocines and their therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100719

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/00 20060101ALI20100713BHEP

Ipc: A61K 8/68 20060101ALI20100713BHEP

Ipc: A61K 31/164 20060101AFI20060922BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110216